Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis.
about
Minimizing the Risk of Bleeding with NOACs in the Elderly.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.
P2860
Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@ast
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@en
type
label
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@ast
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@en
prefLabel
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@ast
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@en
P2093
P2860
P1476
Outcomes After Cardioversion i ...... Insights from a Meta-Analysis.
@en
P2093
Amartya Kundu
Hossam Amin
Partha Sardar
Ramez Nairooz
Saurav Chatterjee
Wilbert S Aronow
P2860
P2888
P356
10.1007/S40256-015-0136-1
P50
P577
2015-07-03T00:00:00Z